Authors: Thurlimann, B Price, KN Castiglione, M Coates, AS Goldhirsch, A Gelber, RD Forbes, J Holmberg, S Veronesi, A Bernhard, J Zahrieh, D

Citation: B. Thurlimann et al., Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93, BREAST, 10, 2001, pp. 130-138

Authors: Roth, AD Maibach, R Martinelli, G Fazio, N Aapro, MS Pagani, O Morant, R Borner, MM Herrmann, R Honegger, H Cavalli, F Alberto, P Castiglione, M Goldhirsch, A

Citation: Ad. Roth et al., Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma, ANN ONCOL, 11(3), 2000, pp. 301-306

Authors: Sabbioni, MEE Siegrist, HP Bacchi, M Bernhard, J Castiglione, M Thurlimann, B Bonnefoi, H Perey, L Herrmann, R Goldhirsch, A Hurny, C

Citation: Mee. Sabbioni et al., Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment, BREAST CANC, 59(3), 2000, pp. 279-287

Authors: Sabbioni, MEE Castiglione, M Hurny, C Siegrist, HP Bacchi, M Bernhard, J Thurlimann, B Bonnefoi, H Perey, L Goldhirsch, A Senn, HJ

Citation: Mee. Sabbioni et al., Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients, SUPP CARE C, 7(3), 1999, pp. 149-153

Authors: Roth, AD Herrmann, R Morant, R Borner, MM Honegger, HP Obrist, R Bacchi, M Lange, J Alberto, P Castiglione, M

Citation: Ad. Roth et al., Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: The SAKK experience, EUR J CANC, 34(13), 1998, pp. 2126-2128